May 2022

Sale of GeneDx, Inc., a Subsidiary of OPKO Health, Inc. (NASDAQ: OPK) to Sema4 Holdings Corp. (SMFR)
Financial Advisor
View DetailsMar 2022
$100 Million

Senior Secured Term Loan & Revenue Interest Finance Agreement (Synthetic Royalty)
Sole Placement Agent and Financial Advisor
View DetailsMar 2022
$100 Million
